The cross-sectional component involves 72 individuals with iAMD. The scotopic MAIA (sMAIA) microperimeter will be contro clinical trials

Dark adaptation and Retinal Topography in AMD (DART-AMD)

This study looks at how people with early AMD adapt to darkness and how their eye changes affect this. It aims to improve tests for new treatments that slow down AMD progression and is for people aged 55-85 with intermediate AMD.